Sugi Predict

Sugi Predict / Compounds / SCHEMBL492013

SCHEMBL492013

SCHEMBL492013

CCOC(=O)c1nsc2cc(Br)ccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ELANE P08246 4/20 0.49
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ TP53 P04637 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ MAPT P10636 3/20 0.44
▸ TARBP2 Q15633 1/20 0.44
▸ GABRA1 P14867 1/20 0.42
▸ GABRB1 P18505 1/20 0.42
▸ GABRA3 P34903 1/20 0.42
▸ GABRB2 P47870 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ KDM4E B2RXH2 3/20 0.42
▸ NPSR1 Q6W5P4 2/20 0.41
▸ DHODH Q02127 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ CYP19A1 P11511 1/20 0.41
▸ TBK1 Q9UHD2 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1635139 0.89 ELANE (0.49) ELANESMN1; SMN2TP53ALDH1A1MAPT
SCHEMBL492210 0.84 CA12 (0.48) ELANESMN1; SMN2TP53ALDH1A1MAPT
SCHEMBL1096910 0.84 ELANE (0.46) ELANESMN1; SMN2TP53MAPTKDM4E
SCHEMBL492326 0.82 KDM4E (0.52) ELANESMN1; SMN2TP53ALDH1A1MAPT
SCHEMBL492447 0.81 GABRA1 (0.39) ELANESMN1; SMN2TP53MAPTGABRA1
SCHEMBL1176572 0.80 TP53 (0.67) ELANESMN1; SMN2TP53MAPTGABRA1
SCHEMBL260308 0.77 RXFP1 (0.41) SMN1; SMN2ALDH1A1MAPTKDM4ENPSR1
SCHEMBL30209249 0.77 RXFP1 (0.41) SMN1; SMN2ALDH1A1MAPTKDM4ENPSR1
SCHEMBL4777702 0.76 DGAT1 (0.39) RXFP1MEN1NPC1CYP1A2CYP2C9
SCHEMBL4700719 0.75 SMN1; SMN2 (0.49) ELANESMN1; SMN2ALDH1A1MAPTGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110506038-B Pesticidal compounds 巴斯夫欧洲公司 2023-11-24 — — CN disclosed
CN-110818704-B Spiro bridged ring compounds, pharmaceutical compositions thereof and uses thereof 广州市恒诺康医药科技有限公司 2023-08-01 — — CN disclosed
EP-3601231-B1 PESTICIDAL COMPOUNDS BASF SE (DE) 2023-05-10 — — EP disclosed
US-11160280-B2 Pesticial compounds BASF SE (DE) 2021-11-02 — — US disclosed
CN-105712945-B 2-substituted oxy-5-methylsulfonyl aryl piperazine amide analogue and preparation method and application thereof 上海翰森生物医药科技有限公司 2020-12-01 — — CN disclosed
EP-3601231-A1 PESTICIDAL COMPOUNDS BASF SE (DE) 2020-02-05 — — EP disclosed
US-20200029566-A1 Pesticial Compounds BASF SE (DE) 2020-01-30 — — US disclosed
US-10221172-B2 Benzothiazole and benzisothiazole-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction VANDERBILT UNIVERSITY (US) 2019-03-05 — — US disclosed
WO-2018177781-A1 PESTICIDAL COMPOUNDS BASF SE (DE) 2018-10-04 — — WO disclosed
US-20180022744-A1 BENZOTHIAZOLE AND BENZISOTHIAZOLE-SUBSTITUTED COMPOUNDS AS MGLUR4 ALLOSTERIC POTENTIATORS, COMPOSITIONS, AND METHODS OF TREATING NEUROLOGICAL DYSFUNCTION VANDERBILT UNIVERSITY 2018-01-25 — — US disclosed
US-8273891-B2 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof MEMORY PHARMACEUTICALS CORPORATION (US) 2012-09-25 — — US disclosed
US-8106066-B2 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof MEMORY PHARMACEUTICALS CORPORATION (US) 2012-01-31 — — US disclosed
US-7932248-B2 3-(1,4-Diazabicyclo[3.2.2]non-4-ylcarbonyl)-5-(tetrahydro-2H-pyran-4-yloxy)-1H-indazole,nicotinic receptor agonists; particularly ligands for the nicotinic alpha-7-receptor(alpha 7 nAChR subtype); brain disorders; neuroprotectants; strokes; antiischemic agents; glutamate-induced excitotoxicity MEMORY PHARMACEUTICALS CORPORATION (US) 2011-04-26 — — US disclosed
US-20100137288-A1 INDAZOLES, BENZOTHIAZOLES, BENZOISOTHIAZOLES, BENZISOXAZOLES, PYRAZOLOPYRIDINES, ISOTHIAZOLOPYRIDINES, AND PREPARATION AND USES THEREOF SCHUMACHER RICHARD 2010-06-03 — — US disclosed
EP-1963332-A1 1 H-INDAZOLES, BENZOTHIAZOLES, 1,2-BENZOISOXAZOLES, 1,2-BENZOISOTHIAZOLES, AND CHROMONES AND PREPARATION AND USES THEREOF Memory Pharmaceuticals Corporation (US) 2008-09-03 — — EP disclosed
EP-1940833-A1 INDAZOLES, BENZOTHIAZOLES, BENZOISOTHIAZOLES, BENZISOXAZOLES, PYRAZOLOPYRIDINES, ISOTHIAZOLOPYRIDINES, AND PREPARATION AND USES THEREOF Memory Pharmaceuticals Corporation (US) 2008-07-09 — — EP disclosed
US-20070135417-A1 3-(1,4-Diazabicyclo[3.2.2]non-4-ylcarbonyl)-5-(tetrahydro-2H-pyran-4-yloxy)-1H-indazole,nicotinic receptor agonists; particularly ligands for the nicotinic alpha-7-receptor(alpha 7 nAChR subtype); brain disorders; neuroprotectants; strokes; antiischemic agents; glutamate-induced excitotoxicity MEMORY PHARMACEUTICALS CORPORATION 2007-06-14 — — US disclosed
WO-2007056582-A1 1 H-INDAZOLES, BENZOTHIAZOLES, 1,2-BENZOISOXAZOLES, 1,2-BENZOISOTHIAZOLES, AND CHROMONES AND PREPARATION AND USES THEREOF MEMORY PHARMACEUTICALS CORPORATION (US) 2007-05-18 — — WO disclosed
US-20070078147-A1 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof MEMORY PHARMACEUTICALS CORPORATION 2007-04-05 — — US disclosed
WO-2007038367-A1 INDAZOLES, BENZOTHIAZOLES, BENZOISOTHIAZOLES, BENZISOXAZOLES, PYRAZOLOPYRIDINES, ISOTHIAZOLOPYRIDINES, AND PREPARATION AND USES THEREOF MEMORY PHARMACEUTICALS CORPORATION (US) 2007-04-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137288-A1 INDAZOLES, BENZOTHIAZOLES, BENZOISOTHIAZOLES, BENZISOXAZOLES, PYRAZOLOPYRIDINES, ISOTHIAZOLOPYRIDINES, AND PREPARATION AND USES THEREOF CHRNA7, CHRNA5, CHRNA2 ELANE 2764/4885SMN1; SMN2 1646/4885TP53 3118/4885
US-11160280-B2 Pesticial compounds PNMT, DDT, NIT2 ELANE 3327/4885SMN1; SMN2 679/4885TP53 4625/4885
US-20180022744-A1 BENZOTHIAZOLE AND BENZISOTHIAZOLE-SUBSTITUTED COMPOUNDS AS MGLUR4 ALLOSTERIC POTENTIATORS, COMPOSITIONS, AND METHODS OF TREATING NEUROLOGICAL DYSFUNCTION GRM4, GRIK4, GRIA4 ELANE 4838/4885SMN1; SMN2 629/4885TP53 4689/4885
US-10221172-B2 Benzothiazole and benzisothiazole-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction GRM4, GRIK4, GRIA4 ELANE 4838/4885SMN1; SMN2 629/4885TP53 4689/4885
US-20070135417-A1 3-(1,4-Diazabicyclo[3.2.2]non-4-ylcarbonyl)-5-(tetrahydro-2H-pyran-4-yloxy)-1H-indazole,nicotinic receptor agonists; particularly ligands for the nicotinic alpha-7-receptor(alpha 7 nAChR subtype); brain disorders; neuroprotectants; strokes; antiischemic agents; glutamate-induced excitotoxicity CHRNA7, CHRNA5, CHRNA3 ELANE 2671/4885SMN1; SMN2 1597/4885TP53 3757/4885
US-20200029566-A1 Pesticial Compounds PNMT, DDT, NIT2 ELANE 3327/4885SMN1; SMN2 679/4885TP53 4625/4885
US-20070078147-A1 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof CHRNA7, CHRNA5, CHRNA2 ELANE 2764/4885SMN1; SMN2 1646/4885TP53 3118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.